Add BrightSurf on Google Email

Stage increase in lung cancer more frequent after open vs. closed thoracic surgery

Research published in Journal of Thoracic Oncology found that non-small cell lung cancer patients with early-stage tumors had a higher rate of nodal upstaging and longer hospital stays when undergoing open chest surgery compared to video-assisted thoracic surgery (VATS). This study suggests that VATS may not be equivalent to open surge...

SourceInternational Association for the Study of Lung Cancer·JournalJournal of Thoracic Oncology·DateJan 11, 2016

Clinical research experts comment on the state of their fields

Clinical research experts discuss various topics, including the impact of personalized genomic data on healthcare systems, strategies to combat multidrug-resistant tuberculosis, and population approaches to reduce diabetes incidence. They also highlight the need for improved cancer diagnosis and treatment for neurodegenerative diseases.

SourcePLOS·JournalPLOS Medicine·DateDec 29, 2015

Low rate of job retention following colorectal cancer diagnosis

A study published in JAMA found that nearly half of working individuals with stage III colorectal cancer lost their jobs due to their diagnosis. However, those with access to paid sick leave were more likely to retain their jobs and experience reduced personal financial burdens. The study highlights the importance of providing paid sic...

SourceJAMA Network·JournalJAMA·DateDec 22, 2015

Even before ACA, cancer survivors in non-expansion states had less health-care access

Even before the Affordable Care Act (ACA), cancer survivors in non-expansion states had limited access to healthcare. The study analyzed data from the 2012 and 2013 Behavioral Risk Factor Surveillance System and found that these survivors were less likely to have a personal doctor, receive an annual checkup, or see a doctor due to cost.

SourceUniversity of Colorado Anschutz Medical Campus·JournalJournal of Cancer Survivorship·DateDec 22, 2015

Journal of Comparative Effectiveness research discusses oncology treatment sequences

The Journal of Comparative Effectiveness Research discusses new recommendations from the Center for Medical Technology Policy's Green Park Collaborative for evaluating oncology treatment sequences. The framework developed by GPC-USA aims to fill evidence gaps and identify patient-important outcomes, ultimately improving cancer patient ...

SourceFuture Science Group·JournalJournal of Comparative Effectiveness Research·DateDec 17, 2015

Continuous joint use of estrogen and progestin lowers risk of EC in postmenopausal women

A study published in JNCI Journal of the National Cancer Institute found that continuous joint use of estrogen and progestin reduces the risk of endometrial cancer by 35% in postmenopausal women. The study analyzed data from 16,608 women aged 50-79 with normal uteri, who were randomly assigned to daily estrogen plus progestin or placebo.

SourceOxford University Press USA·JournalJNCI Journal of the National Cancer Institute·DateDec 14, 2015

Healthy or sick? Tiny cell bubbles may hold the answer

Researchers have identified 335 genes that regulate the formation and function of extracellular vesicles (EVs), tiny bubbles released by cells. EVs can promote tissue repair or carry disease signals for cancer and neurodegenerative diseases like Alzheimer's. Understanding EV biology could lead to new therapeutic treatments.

SourceRutgers University·JournalCurrent Biology·DateDec 11, 2015

Scientists in Barcelona discover a potential treatment for cirrhosis

A study published in Gastroenterology reveals that the inhibition of CPEB4 protein can prevent the development of abnormal blood vessels associated with cirrhosis. This finding has significant implications for the treatment of this disease, which is responsible for a high rate of hospital admissions and use of health resources.

New $4.4 million research project targets obesity

A new $4.4 million research project aims to improve diagnosis and therapies for obesity-related health problems, including coronary heart disease, endometrial cancer, type-2 diabetes, and degenerative joint disease. The project will utilize big data analytics and genomics to gain insights into the causes of obesity.

Rare disease is a lens on cancer

Researchers used a rare genetic childhood disease to reveal how cancer cells hijack a metabolic cycle to benefit themselves. The study found that silencing the ASS1 gene, which is lacking in some patients, can be beneficial for cancer growth and could lead to new treatments.

Optimal care for older cancer patients should target relevant HRQOL domains according to EORTC study

A recent EORTC study identified key health-related quality of life (HRQOL) components to prioritize in caring for older cancer patients. The study found that HRQOL improves with age for social functioning and financial problems, while physical functioning and constipation worsen.

SourceEuropean Organisation for Research and Treatment of Cancer·JournalEuropean Journal of Cancer·DateNov 25, 2015

Blood sample new way of detecting cancer

Researchers developed a new method to detect, classify, and pinpoint cancer location using blood platelet RNA analysis, achieving 96% accuracy. The study identified nearly all cancer types and showed immense potential for improving early cancer detection.

SourceUmea University·JournalCancer Cell·DateNov 12, 2015

Diagnosis before disease breaks out

Researchers at Linköping University have developed a strategy to discover disease progression at its earliest phase by analyzing T-cells. The study found that specific genes can serve as early disease markers, even before symptoms appear.

SourceLinköping University·JournalScience Translational Medicine·DateNov 11, 2015

TCGA findings provide molecular background for second most common kidney cancer

Scientists have molecularly characterized two types of the second most common kidney cancer, papillary renal cell carcinoma (PRCC), which accounts for 15-20% of kidney cancer cases. The study reveals distinct molecular differences between Type 1 and 2 PRCC, as well as three subtypes of Type 2, each with varying molecular alterations. T...

SourceVan Andel Research Institute·JournalNew England Journal of Medicine·DateNov 5, 2015

Skin cancer-causing fusion gene identified

A novel fusion gene NUP160-SLC43A3 has been identified in skin cancer cells, leading to rapid tumor progression and a significantly shorter duration between symptoms onset and hospital visit. This discovery has potential implications for new diagnostic and therapeutic approaches for angiosarcoma.

SourceKumamoto University·JournalCancer Research·DateNov 1, 2015